Ymed, Inc.
United StatesFDA applicant, unverified
- Devices
- 2
What Ymed, Inc. makes
Ymed, Inc. manufactures percutaneous transluminal angioplasty (PTA) dilation catheters, including the VASCUTRAK PTA line and its variants (e.g., V14 and V18 models), designed for vascular interventions to treat stenosis or blockages in blood vessels.
These devices are classified as Class II under FDA regulations and are listed via the 510(k) pathway. The company is based in the United States.
Catalogue
Vascutrak Pta Dilation Catheter Ref K063657
Regimes: 510(k) Registry: 510(k)Vascutrak 2, Models: V14 And V18 Ref K082343
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Ymed, Inc. have in the registry?
The registry currently lists 2 devices for Ymed, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Ymed, Inc.'s devices?
Among its 2 most recently registered devices, Ymed, Inc. has devices listed in FDA 510(k) (2 devices).
What risk classes do Ymed, Inc.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Ymed, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Ymed, Inc. in the registry?
The most recently registered devices listed for Ymed, Inc. include VASCUTRAK PTA DILATION CATHETER and VASCUTRAK 2, MODELS: V14 AND V18.